Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
0.7710
-0.0408 (-5.03%)
At close: Nov 13, 2026, 4:00 PM EST
0.8100
+0.0390 (5.06%)
After-hours: Nov 13, 2026, 7:05 PM EST
Phio Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
9.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 21.00K | -117.00K | -84.78% |
| Dec 31, 2018 | 138.00K | 123.00K | 820.00% |
| Dec 31, 2017 | 15.00K | -4.00K | -21.05% |
| Dec 31, 2016 | 19.00K | -15.00K | -44.12% |
| Dec 31, 2015 | 34.00K | -37.00K | -52.11% |
| Dec 31, 2014 | 71.00K | -328.00K | -82.21% |
| Dec 31, 2013 | 399.00K | 302.00K | 311.34% |
| Dec 31, 2012 | 97.00K | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BioLineRx | 1.39M |
| Longeveron | 1.19M |
| Kiora Pharmaceuticals | 1.00M |
| CytoMed Therapeutics | 609.73K |
| CollPlant Biotechnologies | 318.00K |
| Lexaria Bioscience | 194.00K |
| Addex Therapeutics | 102.81K |
PHIO News
- 9 days ago - Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer) - Newsfile Corp
- 10 days ago - Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation - Newsfile Corp
- 10 days ago - Phio Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 10 days ago - Phio Pharmaceuticals Earnings release: Q3 2026 - Filings
- 27 days ago - Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - Newsfile Corp
- 5 weeks ago - Phio Pharmaceuticals Transcript: Small Cap Growth Hybrid Investor Conference - Transcripts
- 5 weeks ago - Phio Pharmaceuticals to Present at the National Investment Banking Association (NIBA) 153rd Conference - Newsfile Corp
- 7 weeks ago - Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference - Newsfile Corp